Researchers, led by the University of Melbourne's Professor Laura Mackay, a Laboratory Head and Immunology Theme Leader at ...

Significant increases in breast cancer incidence were found among Hispanic, American Indian or Alaska Native, and Asian or ...

HER2-positive (HER2+) breast cancer treatments come with a range of unpleasant side effects. However, there are strategies ...

Breast cancer is the world's most prevalent cancer. Although earlier detection and targeted treatment have resulted in high ...

The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...

15, 2025 — In patients with high-risk HER2-positive breast cancer ... 3D maps of the internal structures of multiple tumor types. These cancer atlases reveal how different tumor cells ...

This innovative model preserves the characteristics of ... Trastuzumab Emtansine Improves Long-Term Survival in HER2 Breast Cancer Jan. 15, 2025 — In patients with high-risk HER2-positive breast ...

Lainie Jones has Li-Fraumeni syndrome, which makes her predisposed to having cancer. She's undergoing treatment for ...

Breast cancer (BC) is the most common malignancy among females worldwide. Breast cancer is a highly heterogeneous malignant tumor which is constitutive of ...

While there currently isn’t a cure for cancer, researchers are exploring several new treatments, including vaccines and gene editing, that could eventually change the face of cancer treatment.

The biotech already sells one drug for HER2-positive breast cancer – oral HER2 inhibitor Nerlynx (neratinib) – and its main R&D focus is on extending its use into multiple breast cancer settings.